Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

A Case of Near-triploidy in Myelodysplastic Syndrome with del(5q) Combined with del(1p) and del(13q)

  • Kim, Bo-Ram (Department of Laboratory Medicine, Dong-A University College of Medicine) ;
  • Kim, Ji-Eun (Department of Laboratory Medicine, Dong-A University College of Medicine) ;
  • Woo, Kwang-Sook (Department of Laboratory Medicine, Dong-A University College of Medicine) ;
  • Kim, Kyeong-Hee (Department of Laboratory Medicine, Dong-A University College of Medicine) ;
  • Kim, Jeong-Man (Department of Laboratory Medicine, Dong-A University College of Medicine) ;
  • Lee, Suee (Department of Internal Medicine, Dong-A University College of Medicine) ;
  • Shaffer, Lisa G. (Signature Genomic Laboratories) ;
  • Han, Jin-Yeong (Department of Laboratory Medicine, Dong-A University College of Medicine)
  • Published : 2012.07.01
⟨ Previous Next ⟩

Abstract

Numerical and structural chromosomal abnormalities are common in hematological malignancies. Near-triploidy (58-80 chromosomes) is a numerical abnormality observed in 3% of adult cases of acute lymphoblastic leukemia. Near-triploidy is rare in myeloid lineage hematologic malignancies and compared to near-triploidy in lymphoid malignancies, neartriploidy in myeloid malignancies is associated with poor outcomes. Few studies on neartriploidy in myelodysplastic syndrome (MDS) have been reported, and the clinicopathologic significance of this condition is still unclear. Here, we report a novel case of MDS with near-triploidy and multiple structural chromosomal abnormalities: del(5q) combined with del(1p) and del(13q). These abnormalities were detected by cytogenetic analysis with array comparative genomic hybridization (CGH). Our results suggest that array CGH can be a useful tool for detecting chromosomal abnormalities in patients with MDS.

Keywords

References

  1. Sabattini E, Bacci F, Sagramoso C, Pileri SA. WHO classification of tumours of haematopoietic and lymphoid tissues. Pathologica 2010;102:83-7.
  2. Sole F, Luno E, Sanzo C, Espinet B, Sanz GF, Cervera J, et al. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes. Haematologica 2005;90:1168-78.
  3. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, et al. Clinical and cytogenetic correlations in 63 patients with therapy- related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 1986;4:325-45. https://doi.org/10.1200/JCO.1986.4.3.325
  4. Stamatoullas A, Callat MP, Marreiros S, Tilly H, Bastard C. Unusual complex hyperdiploid karyotypes in myelodysplastic syndromes. Cancer Genet Cytogenet 2006;170:129-32. https://doi.org/10.1016/j.cancergencyto.2006.05.012
  5. Iyer RV, Sait SN, Matsui S, Block AW, Barcos M, Slack JL, et al. Massive hyperdiploidy and tetraploidy in acute myelocytic leukemia and myelodysplastic syndrome. Cancer Genet Cytogenet 2004;148:29-34. https://doi.org/10.1016/S0165-4608(03)00214-0
  6. Lim G, Oh SH, Choi JR, Lee HJ, Suh JT, Yoon HJ, et al. Leukemic transformation associated with massive hyperdiploidy in myelodysplastic syndrome (MDS) with der(1;7)(q10;p10): a novel case study. Leuk Res 2010;34:e208-9. https://doi.org/10.1016/j.leukres.2010.02.027
  7. Znoyko I, Stuart RK, Ellingham T, Winters J, Wolff DJ, Quigley DI. Tetraploidy and 5q deletion in myelodysplastic syndrome: a case report. Cancer Genet Cytogenet 2008;183:64-8. https://doi.org/10.1016/j.cancergencyto.2008.01.022
  8. Acar H, Cali kan U U, Kaynak M, Yildirim MS, Largaespada DA. Hyperdiploid karyotype in a childhood MDS patient. Clin Lab Haematol 2001;23:255-8. https://doi.org/10.1046/j.1365-2257.2001.00396.x
  9. Manley R, Cochrane J, Patton WN. Polyploidy in myelodysplastic syndrome: a case report. Cancer Genet Cytogenet 1998;106:170-2. https://doi.org/10.1016/S0165-4608(98)00058-2
  10. Tanaka M, Takeuchi H, Kaku K, Oka Y. Myelodysplastic syndrome associated with hypotriploidy. Acta Haematol 1996;95:148-50. https://doi.org/10.1159/000203865
  11. Bacher U, Haferlach T, Kern W, Weiss T, Schnittger S, Haferlach C. The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes. Cancer 2009;115:4524-32. https://doi.org/10.1002/cncr.24501
  12. Kawankar N and Vundinti BR. Cytogenetic abnormalities in myelodysplastic syndrome: an overview. Hematology 2011;16:131-8. https://doi.org/10.1179/102453311X12940641877966
  13. Shaffer LG, Slovak MI, Campbell LJ, eds. An International System for Human Cytogenetic Nomenclature (ISCN). Basel: S, Karger, 2009:36- 84.
  14. Hu J, Gao JB, Cao Y, Bottinger E, Zhang W. Exploiting noise in array CGH data to improve detection of DNA copy number change. Nucleic Acids Res 2007;35:e35. https://doi.org/10.1093/nar/gkl730
  15. Watanabe A, Inokuchi K, Yamaguchi H, Mizuki T, Tanosaki S, Shimada T, et al. Near-triploidy and near-tetraploidy in hematological malignancies and mutation of the p53 gene. Clin Lab Haematol 2004;26:25-30. https://doi.org/10.1111/j.0141-9854.2003.00574.x
  16. Sheth FJ, Sheth JJ, Desai C. Case of near triploidy with i(17)(q10) in blast crisis CML. Cancer Genet Cytogenet 2006;164:177-8. https://doi.org/10.1016/j.cancergencyto.2005.07.022
  17. Roland B and Blahey WB. A case of near-triploidy in chronic myelogenous leukemia. Cancer Genet Cytogenet 2000;121:96-8. https://doi.org/10.1016/S0165-4608(00)00227-2
  18. Mallo M, Cervera J, Schanz J, Such E, García-Manero G, Luño E, et al. Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q. Leukemia 2011;25:110-20. https://doi.org/10.1038/leu.2010.231
  19. Lee HR, Oh B, Hong DS, Zang DY, Yoon HJ, Kim HJ, et al. Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization. Cancer Genet Cytogenet 2010;203:193-202. https://doi.org/10.1016/j.cancergencyto.2010.08.007
  20. Martinez-Ramirez A, Urioste M, Melchor L, Blesa D, Valle L, de Andres SA, et al. Analysis of myelodysplastic syndromes with complex karyotypes by high-resolution comparative genomic hybridization and subtelomeric CGH array. Genes Chromosomes Cancer 2005;42:287-98. https://doi.org/10.1002/gcc.20154
  21. Praulich I, Tauscher M, Gohring G, Glaser S, Hofmann W, Feurstein S, et al. Clonal heterogeneity in childhood myelodysplastic syndromeschallenge for the detection of chromosomal imbalances by array-CGH. Genes Chromosomes Cancer 2010;49:885-900. https://doi.org/10.1002/gcc.20797